相似文献
1
Antiarrhythmic effects of DPI 201-106.
Br J Pharmacol. 1986 Oct;89(2):287-92. doi: 10.1111/j.1476-5381.1986.tb10258.x.
2
Effects of dantrolene sodium in rodent models of cardiac arrhythmia.
Eur J Pharmacol. 1989 May 30;164(3):521-30. doi: 10.1016/0014-2999(89)90260-4.
3
Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
Arzneimittelforschung. 1983;33(9):1258-68.
4
Effects of AH-1058, a new antiarrhythmic drug, on experimental arrhythmias and cardiac membrane currents.
J Cardiovasc Pharmacol. 1999 Apr;33(4):625-32. doi: 10.1097/00005344-199904000-00016.
5
Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide.
Arch Int Pharmacodyn Ther. 1978 Jan;231(1):104-30.
6
BW A256C, a chemically novel class 1 antiarrhythmic agent. A comparison of in vitro and in vivo activity with other class 1 antiarrhythmic agents.
Br J Pharmacol. 1986 Jun;88(2):333-43. doi: 10.1111/j.1476-5381.1986.tb10209.x.
7
Interaction of DPI 201-106 with cardiac glycosides.
J Cardiovasc Pharmacol. 1989 Feb;13(2):342-7. doi: 10.1097/00005344-198902000-00026.
8
[Antiarrhythmic effect of TJ0711].
Yao Xue Xue Bao. 2014 Mar;49(3):419-26.
9
Reversal of the cardiotonic and action-potential prolonging effects of DPI 201-106 by BDF 8784, a methyl-indol derivative.
Br J Pharmacol. 1989 Apr;96(4):807-16. doi: 10.1111/j.1476-5381.1989.tb11888.x.
10
Antiarrhythmic effects of two new propafenone related drugs. A study on four animal models of arrhythmia.
Arzneimittelforschung. 1991 Feb;41(2):119-24.
引用本文的文献
1
The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines.
Cancer Lett. 2018 Oct 10;434:81-90. doi: 10.1016/j.canlet.2018.07.022. Epub 2018 Jul 18.
2
Characterization of the inotropic and arrhythmogenic action of the sodium channel activator BDF 9148: a comparison to its S-enantiomer BDF 9196, to its congener DPI 201-106, to norepinephrine, and to ouabain.
Basic Res Cardiol. 1994 Jan-Feb;89(1):61-79. doi: 10.1007/BF00788678.
3
Inhibition of the sodium pump by cardioactive DPI 201-106.
Br J Pharmacol. 1987 May;91(1):3-5. doi: 10.1111/j.1476-5381.1987.tb08975.x.
4
Interactions of DPI 201-106, a novel cardiotonic agent, with cardiac calcium channels.
Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):684-91. doi: 10.1007/BF00165635.
5
Reversal of the cardiotonic and action-potential prolonging effects of DPI 201-106 by BDF 8784, a methyl-indol derivative.
Br J Pharmacol. 1989 Apr;96(4):807-16. doi: 10.1111/j.1476-5381.1989.tb11888.x.
6
Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine.
Naunyn Schmiedebergs Arch Pharmacol. 1991 Oct;344(4):478-87. doi: 10.1007/BF00172589.
本文引用的文献
1
Drugs with a class III antiarrhythmic action.
Pharmacol Ther. 1982;17(3):315-55. doi: 10.1016/0163-7258(82)90020-1.
2
Digitalis.
Pharmacol Ther. 1982;18(1):1-89. doi: 10.1016/0163-7258(82)90026-2.
3
An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents.
Br J Pharmacol. 1984 Jun;82(2):349-57. doi: 10.1111/j.1476-5381.1984.tb10769.x.
4
Methods for the detection and assessment of antiarrhythmic activity.
Pharmacol Ther. 1984;24(3):401-33. doi: 10.1016/0163-7258(84)90011-1.
5
How increased sodium influx enhances digoxin-induced arrhythmias in guinea-pig atrial muscle.
Eur J Pharmacol. 1983 May 6;89(3-4):199-209. doi: 10.1016/0014-2999(83)90495-8.
6
Myocardial concentration of norepinephrine and cyclic AMP in ventricular fibrillation during acute myocardial ischemia.
J Cardiovasc Pharmacol. 1982 Nov-Dec;4(6):1018-23. doi: 10.1097/00005344-198211000-00022.
7
The mode of antiarrhythmic action of melperone.
Acta Pharmacol Toxicol (Copenh). 1982 Feb;50(2):108-12. doi: 10.1111/j.1600-0773.1982.tb00950.x.
8
Local anesthetics: effect of pH on activity.
Science. 1968 Dec 20;162(3860):1394-5. doi: 10.1126/science.162.3860.1394.
9
Action of prilocaine on the vagus nerve and on adrenaline induced extrasystole in dogs.
Arch Int Pharmacodyn Ther. 1967 Oct;169(2):302-7.
10
DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties.
Naunyn Schmiedebergs Arch Pharmacol. 1985 May;329(3):316-25. doi: 10.1007/BF00501887.
Zotero 插件